MEMORANDUM OF UNDERSTANDING February 1, 2014
Exhibit 10.123
February 1, 2014
This “MOU”, by and between VG Life Sciences Inc., a Delaware corporation (“VGLS”), and Tg IT, Inc., dba “Anchor Point IT-Solutions,” a California corporation (“Anchor Point”), with respect to mutual agreement for VGLS and Anchor Point to enter into a 1-year consulting service agreement, where Anchor Point will provide IT support and on-call services.
The understanding and agreement of VGLS and Anchor Point with respect to such IT Support and on-call services embodied in this MOU is as follows:
1. Both parties desire to agree to payment in the form of shares for services previously provided to VGLS, as well as for services to be provided to VGLS.
2. All services provided by Anchor Point beginning January 1, 2014 will be valued at an average closing stock price of 20 days pre-closing of this transaction and all cost of Anchor Point in providing the services shall be paid in shares of VGLS common stock.
3. Both parties value such future support and service to be at a Six-Hundred Dollars ($600.00) per month to be reviewed and adjusted quarterly as needed as amendments to this agreement.
4. Services provided between October 1, 2013 and December 31, 2013 will be valued at an average closing stock price of 20 days pre-closing December 31, 2013 and shall be paid in shares of VGLS common stock. These shares will be issued within 30 days of the signing of this agreement. The value of services for this period is reflected in Exhibit A to this MOU.
5. Services provided prior to October 1, 2013 will be valued at an average closing stock price of 20 days pre-closing September 30, 2013 and shall be paid in shares of VGLS common stock. These shares will be issued within 30 days of the signing of this agreement. The value of services for this period is reflected in Exhibit A to this MOU.
6. Shares will be earned quarterly on the last day of each quarter.
It is the intention of VGLS and Anchor Point to negotiate in good faith and enter into a long-form agreement (the “Long-Form Agreement”) within the next 60 days after the date of this MOU, which shall be based upon, and shall be consistent with, the terms and provisions of this MOU.
Until the Long-Form Agreement is entered into (or if in no Long-Form Agreement is entered into); this MOU shall constitute a legal and valid agreement between VGLS and Anchor Point with respect to its subject matter. This MOU sets forth the entire understanding and agreement of VGLS and Anchor Point with respect to the subject matter hereof and it may not be amended or modified, except by a written instrument executed by VGLS and Anchor Point.
If this MOU meets with your approval and sets for the preliminary understanding agreement of VGLS and Anchor Point with respect to the subject matter hereof, please have it signed by a duly authorized officer of Anchor Point and return it to the undersigned.
Very truly yours, | |
VG Life Sciences Inc. | |
By: /s/ Xxxx Xxxxx | |
Xxxx Xxxxx | |
President & CEO |
Agreed and Accepted
As of the 1st day of
February 2014
Tg IT, Inc. (dba Anchor Point IT Solutions)
By: /s/ Xxxx XxXxxx
Title: Xxxx XxXxxx
Its: Principal
Anchor Point
02/28/14
A/R Aging QuickZoom
As of January 31, 2014
Type | Date | Num | P.O. # | Name | Terms | Due Date | Aging | Open Balance |
VG Life Sciences | ||||||||
Invoice | 09/01/2011 | 4353 | VG Life Sciences | Net 30 | 10/01/2011 | 853 | 122.32 | |
Invoice | 10/01/2011 | 4444 | VG Life Sciences | Net 30 | 10/31/2011 | 823 | 613.88 | |
Invoice | 11/01/2011 | 4548 | VG Life Sciences | Net 30 | 12/01/2011 | 792 | 600.00 | |
Invoice | 12/01/2011 | 4649 | VG Life Sciences | Net 30 | 12/31/2011 | 762 | 600.00 | |
Invoice | 01/01/2012 | 4739 | VG Life Sciences | Net 30 | 01/31/2012 | 731 | 600.00 | |
Invoice | 03/01/2012 | 4985 | VG Life Sciences | Due Upo... | 03/01/2012 | 701 | 600.00 | |
Invoice | 04/01/2012 | 5039 | VG Life Sciences | Due Upo... | 04/01/2012 | 670 | 600.00 | |
Invoice | 05/01/2012 | 5139 | VG Life Sciences | Due Upo... | 05/01/2012 | 640 | 600.00 | |
Invoice | 06/01/2012 | 5238 | VG Life Sciences | Due Upo... | 06/01/2012 | 609 | 600.00 | |
Invoice | 07/01/2012 | 5341 | VG Life Sciences | Due Upo... | 07/01/2012 | 579 | 600.00 | |
Invoice | 08/01/2012 | 5443 | VG Life Sciences | Due Upo... | 08/01/2012 | 548 | 600.00 | |
Invoice | 09/01/2012 | 5538 | VG Life Sciences | Due Upo... | 09/01/2012 | 517 | 600.00 | |
Invoice | 10/01/2012 | 5640 | VG Life Sciences | Due Upo... | 10/01/2012 | 487 | 600.00 | |
Invoice | 11/01/2012 | 5748 | VG Life Sciences | Due Upo... | 11/01/2012 | 456 | 600.00 | |
Invoice | 12/01/2012 | 5857 | VG Life Sciences | Due Upo... | 12/01/2012 | 426 | 600.00 | |
Invoice | 01/01/2013 | 5959 | VG Life Sciences | Due Upo... | 01/01/2013 | 395 | 600.00 | |
Invoice | 02/01/2013 | 6073 | VG Life Sciences | Due Upo... | 02/01/2013 | 364 | 600.00 | |
Invoice | 03/01/2013 | 6173 | VG Life Sciences | Due Upo... | 03/01/2013 | 336 | 600.00 | |
Invoice | 04/01/2013 | 6268 | VG Life Sciences | Due Upo... | 04/01/2013 | 305 | 600.00 | |
Invoice | 05/01/2013 | 6369 | VG Life Sciences | Due Upo... | 05/01/2013 | 275 | 600.00 | |
Invoice | 06/01/2013 | 6463 | VG Life Sciences | Due Upo... | 06/01/2013 | 244 | 600.00 | |
Invoice | 06/30/2013 | 6675 | VG Life Sciences | Due Upo... | 06/30/2013 | 215 | 25.34 | |
Invoice | 07/01/2013 | 6584 | VG Life Sciences | Due Upo... | 07/01/2013 | 214 | 600.00 | |
Invoice | 08/01/2013 | 6732 | VG Life Sciences | Due Upo... | 08/01/2013 | 183 | 600.00 | |
Invoice | 08/31/2013 | 6911 | VG Life Sciences | Due Upo... | 08/31/2013 | 153 | 991.77 | |
Invoice | 09/01/2013 | 6861 | VG Life Sciences | Due Upo... | 09/01/2013 | 152 | 600.00 | |
Invoice | 09/30/2013 | 7034 | VG Life Sciences | Due Upo... | 09/30/2013 | 123 | 29.98 | |
Invoice | 10/01/2013 | 6965 | VG Life Sciences | Due Upo... | 10/01/2013 | 122 | 600.00 | |
Invoice | 11/01/2013 | 7126 | VG Life Sciences | Due Upo... | 11/01/2013 | 91 | 629.98 | |
Invoice | 12/01/2013 | 7219 | VG Life Sciences | Due Upo... | 12/01/2013 | 61 | 629.98 | |
Invoice | 12/31/2013 | 7398 | VG Life Sciences | Due Upo... | 12/31/2013 | 31 | 29.98 | |
Invoice | 01/01/2014 | 7347 | VG Life Sciences | Due Upo... | 01/01/2014 | 30 | 600.00 | |
Invoice | 01/31/2014 | 7546 | VG Life Sciences | Due Upo... | 01/31/2014 | 29.98 | ||
Total VG Life Sciences | 17,503.21 | |||||||
TOTAL | 17,503.21 |